Xenon Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-89.9M | $60.2M |
| FY2013 | — | $-78.4M | $38.0M |
| FY2014 | — | $72.8M | $72.0M |
| FY2015 | — | $61.0M | $58.7M |
| FY2016 | — | $63.9M | $17.1M |
| FY2017 | $6.1M | $35.9M | $20.5M |
| FY2018 | $15.0M | $103.3M | $67.8M |
| FY2019 | $10.9M | $92.0M | $24.8M |
| FY2020 | — | $171.4M | $45.0M |
| FY2021 | — | $550.0M | $175.7M |
| FY2022 | — | $721.5M | $57.2M |
| FY2023 | — | $927.9M | $148.6M |
| FY2024 | — | $754.9M | $142.7M |
| FY2025 | — | $581.8M | $199.2M |